At the conclusion of this education activity, participants should be able to:

• Review and apply the new guidelines of treatment of lupus and lupus nephritis
• Explain the approach and management of difficult-to-treat RA cases
• Recognize the unique role of rheumatology in the multidisciplinary approach to sarcoidosis
• Describe the mechanism and implementation of Car-T in rheumatic disease
• Implement treatments that minimize the risk of infectious disease in patients with rheumatic diseases
• Recognize presentation and new treatment options for IgG4-related disease
• Discuss presentation and evidence-based strategies for the management of APS
• Describe the importance of empathy to maximize physician and patient well-being
• Describe clinical advances in the field of rheumatology over the past year.
• List advocacy organizations and recognize the importance of a collaborative approach to promote better patient care.
• Recognize some of the rare diseases and rare manifestations of rheumatic diseases, as well as treatment approaches to such cases. 
• Demonstrate how to address and treat more complicated patients within specific areas of rheumatology, including patients who are refractory to treatments and patients with challenging diagnostic dilemmas.
• Recognize treatment options available for patients with gout, understand which patients are candidates for more aggressive treatment, and recognize implications of newer treatments including potential adverse events and mitigation strategies. 

• The Omni | Charlotte, NC
• Conference registration open until March 6
• Hotel reservations must be by 5:00 p.m. on Feb. 13
• Hotel Reservations